The deep love we feel for our Almighty Lord, Who created us from nothing, is a deep-rooted one consisting of a combination of several emotions. It contains a feeling of submission towards our Almighty Lord, a powerful feeling of trust in the infinite mercy of Allah, respect for His omniscience, and awe in the face of the beauties created by Him. There is also a faithfulness and devotion stemming from the knowledge that Allah is Lord of all. Someone who is aware of all these is bound to our Lord with a most joyous love. That love is true and pure. The love that believers feel for our Lord is described as follows in the Qur’an:
Some people set up equals to Allah, loving them as they should love Allah. But those who believe have greater love for Allah. If only you could see those who do wrong at the time when they see the punishment, and that truly all strength belongs to Allah, and that Allah is severe in punishment. (Surat al-Baqara,165)
Subscribe to:
Post Comments (Atom)
2 comments:
Thank you so much @ admin for share your valuable thoughts and ideas We always enjoy your articles its inspired a lot by reading your articles day by day. So please accept my thanks and congrats for success of your latest series. We hope, you should published more better articles like ever before
Tele calling solutions
Politics & FDA clearance of 2 stem cell clinic COVID-19 efforts
FDA is doing better job on unproven stem cell clinics, but it has cleared many INDs, some iffy, for stem cell and cellular medicine trials for COVID-19.
The FDA and its CBER branch have been doing a good job overall in the last 3+ years to tackle the unproven stem cell clinic problem, but lately on the stem cells for COVID-19 front there is reason for real concern.
I believe the agency is taking on major risk overall by clearing a vast number of cell therapy trials for COVID-19 mostly without much data, but the clearance of a few programs by for-profit stem cell clinics is especially problematic in my view.
FDA on the ball more generally on clinics
For background and on the positive, the FDA is taking the problem of the stem cell clinic industry very seriously and taking action on clinic firms that are injecting patients with unapproved stem cell drugs.
It has sent off dozens of untitled and warning letters to clinic firms pitching unproven stem cells and other regenerative biologics like exosomes. The agency’s biologics branch called CBER is really on the ball on this these days. Its Director Peter Marks deserves big kudos for the serious commitment and marathon work here over many years to make things happen on this problem. Dr. Marks was the subject of an interesting piece in the WaPo by Laurie McGinley recently: Meet the most important federal official you probably don’t know — the man who holds the fate of the coronavirus vaccine in his hands.
Post a Comment